Publication | Open Access

The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance

Breast OncologyUncertainty QuantificationStructural UncertaintyCost-effectiveness ModelsMedicineCancer ManagementPharmacoeconomicsBiostatisticsBreast CancerCost EffectivenessBreast SurgeryOncologyStatisticsDisease-specific Model Standardization